29 rue Jeanne Marvig
31460 Toulouse, France




Project leader

Mr Guillaume Costecalde, Msc, MBA
Phone +33 6 11 34 28 30
Fax +33 5 34 31 68 16

Project staff

Dr. Vincent Fontaine, Ph D
Phone +33 1 60 87 89 32
Fax +33 1 60 87 89 99


Dr. Lucile Tran
Phone +33 1 60 87 89 32
Fax + 33 1 60 87 89 99


Institute presentation

Univercell-Biosolutions has coupled the potential of human hiPS and hES cells with cellular reprogramming and directed differentiation technologies. Together these innovations yield purified populations of specific human cell types for drug-discovery applications. Univercell-Biosolutions has developed Mesopure® to provide a pure (>99%) population of cardiovascular progenitors.

Univercell-Biosolutions works with clinicians, academics and industry leaders to develop next-generation homogeneous, mature, functional and differentiated human cells with physiological characteristics closely matching those of adult differentiated cells in vivo.
Univercell-Biosolutions’ goals are to accelerate the discovery of new therapeutics and to reduce the drug failure rate in clinical trials.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Until you give your consent, only those cookies necessary to maintain the website's functionality are active. When you choose "OK", so called third-party non-functional cookies (e.g. GDPR-conform Google Analytics) may also become active. Please be aware that the website's functionality may be restricted if you choose "DECLINE". You can revoke your choice at any time by clearing your browser cache/history and updating your selection. Please also view our privacy policy.
Ok Decline